Inspiremd is pure junk trading on the NYSE under the ticker NSPR.

With executive offices in Tel Aviv, Israel and the company creates medical devices for coronary and neurovascular disease. This company is the smallest of microcaps with a capitalization of under $7M with negative earnings. This play is an example of looking at smaller timeframes on the day. 

5 years ago the stock was trading at $975; the stock price as of yesterday's close is $0.20 a share.  A 5 year view of the chart shows the stock price flat.  Looking at the 1 year view the stock is down 95% from January a year ago. However this week, those who placed a 10,000 share position when the stock was trading at $0.13 caught the ride up to $0.20 and banked a nice $700.

Stock price is up as a Schedule 4A Form and an 8K Form was filed with the SEC yesterday, there will be an upcoming shareholder meeting.  Recommendation is to take no more than a 10,000 share short position on the second red day and ride the downside as it drops back to below $0.15 a share.  Be happy with a win of a nickel a share and move on to the next trade. Average daily trading volume for NSPR is normally 1.8 million shares but average daily trading volume for NSPR is up to 4.5 million shares in the last two months; 10% of all shares in the float are short. There are 52 million shares outstanding, with 5.7 million shares held by insiders and institutions, there are 46 million shares in the public float. 

This company's proprietary technology is a stent device called MicroNet and Inspiremd just received regulatory approval to penetrate the Indian market for their trademarked CGuard Embolism Prevention System.

Currently the stock is up to $0.29 pre-market. 

Update as of January 23rd: CONGRATS for those traders who took a 10,000 share SHORT position on January 9th when the stock was trading at $0.27 a share, and banked a nice $700 when the stock was at $0.27 by Jan 10th.  To those who continued to hold a SHORT position for the next 3 days saw the stock trade as low as $0.15 before rebounding.